Volume 148, Issue 2, Pages e35-e37 (August 2015) Use of Lenalidomide in 5q-Myelodysplastic Syndrome Provides Novel Treatment Prospects in Management of Pulmonary Sarcoidosis Mahsa Jafari Giv, MBBS (Honours), Alam Yoosuff, MBBS (Honours), MPH, Ali Bazargan, MD CHEST Volume 148, Issue 2, Pages e35-e37 (August 2015) DOI: 10.1378/chest.14-2529 Copyright © 2015 The American College of Chest Physicians Terms and Conditions
Figure 1 Chest CT scan with contrast, prior to treatment with lenalidomide, demonstrating a number of irregular masses. CHEST 2015 148, e35-e37DOI: (10.1378/chest.14-2529) Copyright © 2015 The American College of Chest Physicians Terms and Conditions
Figure 2 Chest CT scan with contrast 4 mo after therapy with lenalidomide, showing interval resolution of masses and clearance of bibasal alveolar infiltrates. CHEST 2015 148, e35-e37DOI: (10.1378/chest.14-2529) Copyright © 2015 The American College of Chest Physicians Terms and Conditions